Skip to main content
Fig. 2 | Trials

Fig. 2

From: Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease

Fig. 2

Schedule of enrolment, interventions and assessment. *Extracted from GP EPR. **Combination of: linkage to HES/ONS data, extraction from GP EPR, participant self-reporting, and reporting by GP and hospitals

Back to article page

Trials

ISSN: 1745-6215